Featured method note
Cold Email Software Ranked by Control and Workflow Fit
Compare leading cold email systems by approval, suppression, reply handling, auditability, and workflow fit.
2026-09-04 · Julian Hartwell
Featured method note
Compare leading cold email systems by approval, suppression, reply handling, auditability, and workflow fit.
2026-09-04 · Julian Hartwell
Turn targeting evidence into a concise, transparent email with a controlled next step.
Read moreA practical six-gate evaluation checklist for revenue operations teams choosing a B2B contact data platform. Covers email verification methods, enrichment source metadata, intent signal accuracy, workflow architecture and compliance — written from okkigo's quality and brand compliance perspective.
Read moreComparing okkigo alternatives? Here's how AI sales assistant features differ from an agent-native prospecting workflow — across human review, data quality, email sequences, and failure modes.
Read moreDiscover a structured approach to lead generation for manufacturers, integrating problem fit and production feasibility from initial RFQ to final targeting
Read moreLearn how to transform opaque website development decisions into concrete diagnostics for effective lead generation, following a step-by-step workshop appr
Read moreA revenue operations lead with six years of data tooling experience shares how Kaspr vs Lusha really plays out, what the best Kaspr alternatives have in common, and what RevOps teams should evaluate in sales email—from verification depth and cold email deliverability to the true cost of unverified contacts.
Read moreA practical six-step checklist for B2B sales teams evaluating prospecting platforms—covering lead enrichment in agent-native workflows, LinkedIn extensions, email sequences, and true total cost of ownership.
Read moreUse AI for research and drafting while preserving provenance, suppression, claim review, permissions, and human send approval.
Read moreBuild firmographic segments only when they produce distinct, repeatable, and testable go-to-market treatment for their members.
Read more